UB Paderborn / Katalog / Suche / in CDI

F16357, a novel protease‐activated receptor 1 antagonist, improves urodynamic parameters in a rat model of interstitial cystitis

British journal of pharmacology, 2016-07, Vol.173 (14), p.2224-2236

2016

Volltextzugriff (PDF)

Sulfonamide derivatives of benzylamine block cholesterol biosynthesis in HepG2 cells : A new type of potent squalene epoxidase inhibitors

Bioorganic & medicinal chemistry letters, 1998-06, Vol.8 (11), p.1337-1342

1998

Volltextzugriff (PDF)

(Aryloxy)methylsilane Derivatives as New Cholesterol Biosynthesis Inhibitors: Synthesis and Hypocholesterolemic Activity of a New Class of Squalene Epoxidase Inhibitors

Journal of medicinal chemistry, 1995-08, Vol.38 (17), p.3207-3216

1995

Volltextzugriff (PDF)

Endothelium-Dependent Contractions Are Associated With Both Augmented Expression of Prostaglandin H Synthase-1 and Hypersensitivity to Prostaglandin H2 in the SHR Aorta

Circulation research, 1995-06, Vol.76 (6), p.1003-1010

1995

Volltextzugriff (PDF)

Pharmacological analysis of wild-type alpha, gamma and delta subtypes of the human peroxisome proliferator-activated receptor

Naunyn-Schmiedeberg's archives of pharmacology, 2002-02, Vol.365 (2), p.133-140

2002

Volltextzugriff (PDF)

PPARα and PPARδ activators inhibit cytokine-induced nuclear translocation of NF-κB and expression of VCAM-1 in EAhy926 endothelial cells

European journal of pharmacology, 2002-01, Vol.435 (2), p.143-151

2002

Volltextzugriff (PDF)

Interleukin-1 β induces the production of an L-arginine-derived relaxing factor from cultured smooth muscle cells from rat aorta

Biochemical and biophysical research communications, 1991-04, Vol.176 (1), p.114-121

1991

Volltextzugriff (PDF)

Retinoids enhance the number of EGF receptors in corneal endothelial cells

Experimental eye research, 1990-07, Vol.51 (1), p.49-53

1990

Volltextzugriff (PDF)

Platelet-Derived Growth Factor Suppresses and Fibroblast Growth Factor Enhances Cytokine-Induced Production of Nitric Oxide by Cultured Smooth Muscle Cells: Effects on Cell Proliferation

Circulation research, 1992-11, Vol.71 (5), p.1088-1100

1992

Volltextzugriff (PDF)

Inhibition of cytokine-induced nitric oxide production by transforming growth factor-beta 1 in human smooth muscle cells

The Journal of physiology, 1992-08, Vol.454 (1), p.451-465

1992

Volltextzugriff (PDF)

F 12511, a novel ACAT inhibitor, and atorvastatin regulate endogenous hypercholesterolemia in a synergistic manner in New Zealand rabbits fed a casein-enriched diet

Atherosclerosis, 2001-03, Vol.155 (1), p.131-142

2001

Volltextzugriff (PDF)

Human adipocyte fatty acid-binding protein (aP2) gene promoter-driven reporter assay discriminates nonlipogenic peroxisome proliferator-activated receptor gamma ligands

The Journal of pharmacology and experimental therapeutics, 2004-11, Vol.311 (2), p.467

2004

Volltextzugriff (PDF)

Design and synthesis of new hypocholesterolemic organosilanes with antioxidant properties

Bioorganic & medicinal chemistry letters, 1996-03, Vol.6 (5), p.533-538

1996

Volltextzugriff (PDF)

F 12511, a novel ACAT inhibitor, and atorvastatin regulate endogenous hypercholesterolemia in a synergistic manner in the casein-fed rabbits

Atherosclerosis, 2000-07, Vol.151 (1), p.130-131

2000

Volltextzugriff (PDF)

Antiatherosclerotic effect of the ACAT inhibitor F 12511 in casein-fed New-Zealand rabbit

Atherosclerosis, 2000-07, Vol.151 (1), p.131-131

2000

Volltextzugriff (PDF)

Powerful antioxidant acat inhibitors exhibit in vitro anti-inflammatory properties

Atherosclerosis, 1999-05, Vol.144, p.119-119

1999

Volltextzugriff (PDF)

Platelet inhibition by an L-arginine-derived substance released by IL-1 beta-treated vascular smooth muscle cells

American journal of physiology. Heart and circulatory physiology, 1991-12, Vol.261 (6), p.H2024-H2030

1991

Volltextzugriff (PDF)

The induction of nitric oxide synthase activity is inhibited by TGF-beta 1, PDGFAB and PDGFBB in vascular smooth muscle cells

European journal of pharmacology, 1992-06, Vol.216 (3), p.379-383

1992

Volltextzugriff (PDF)

366 F16357 regulates in vitro bladder contractility mediated by Protease Activated Receptors

European urology supplements : official journal of the European Association of Urology, 2014-04, Vol.13 (1), p.e366-e366

2014

Volltextzugriff (PDF)

Sulfonamide derivatives of benzylamine block cholesterol biosynthesis in HepG 2 cells: A new type of potent squalene epoxidase inhibitors

Bioorganic & medicinal chemistry letters, 1998-06, Vol.8 (11), p.1337-1342

1998

Volltextzugriff (PDF)

Transforming growth factor-beta 1 inhibits L-arginine-derived relaxing factor(s) from smooth muscle cells

American journal of physiology. Heart and circulatory physiology, 1992-06, Vol.262 (6), p.H1788-H1795

1992

Volltextzugriff (PDF)

Metabolic syndrome: which definition for what treatment(s)?

M.S. Médecine sciences, 2005-12, Vol.21 (12), p.1045-1053

2005

Volltextzugriff (PDF)

Antipsychotic induced-hepatic gene dysregulations correlate with clinical metabolic side effects: A hypothesis of direct action on liver

The international journal of neuropsychopharmacology, 2008-07, Vol.11, p.254

2008

Volltextzugriff (PDF)

Retinoid-Induced Potentiation of Epidermal Growth Factor Mitogenic Effect on Corneal Endothelial Cells

Cornea, 1990-01, Vol.9 (1), p.41-44

1990

Volltextzugriff (PDF)

Cardiovascular drugs inhibit MMP-9 activity from human THP-1 macrophages

DNA and cell biology, 2004-05, Vol.23 (5), p.283

2004

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

F16357, a novel protease‐activated receptor 1 antagonist, improves urodynamic parameters in a rat model of interstitial cystitis

Sulfonamide derivatives of benzylamine block cholesterol biosynthesis in HepG2 cells : A new type of potent squalene epoxidase inhibitors

(Aryloxy)methylsilane Derivatives as New Cholesterol Biosynthesis Inhibitors: Synthesis and Hypocholesterolemic Activity of a New Class of Squalene Epoxidase Inhibitors

Endothelium-Dependent Contractions Are Associated With Both Augmented Expression of Prostaglandin H Synthase-1 and Hypersensitivity to Prostaglandin H2 in the SHR Aorta

Pharmacological analysis of wild-type alpha, gamma and delta subtypes of the human peroxisome proliferator-activated receptor

PPARα and PPARδ activators inhibit cytokine-induced nuclear translocation of NF-κB and expression of VCAM-1 in EAhy926 endothelial cells

Interleukin-1 β induces the production of an L-arginine-derived relaxing factor from cultured smooth muscle cells from rat aorta

Retinoids enhance the number of EGF receptors in corneal endothelial cells

Platelet-Derived Growth Factor Suppresses and Fibroblast Growth Factor Enhances Cytokine-Induced Production of Nitric Oxide by Cultured Smooth Muscle Cells: Effects on Cell Proliferation

Inhibition of cytokine-induced nitric oxide production by transforming growth factor-beta 1 in human smooth muscle cells

F 12511, a novel ACAT inhibitor, and atorvastatin regulate endogenous hypercholesterolemia in a synergistic manner in New Zealand rabbits fed a casein-enriched diet

Human adipocyte fatty acid-binding protein (aP2) gene promoter-driven reporter assay discriminates nonlipogenic peroxisome proliferator-activated receptor gamma ligands

Design and synthesis of new hypocholesterolemic organosilanes with antioxidant properties

F 12511, a novel ACAT inhibitor, and atorvastatin regulate endogenous hypercholesterolemia in a synergistic manner in the casein-fed rabbits

Antiatherosclerotic effect of the ACAT inhibitor F 12511 in casein-fed New-Zealand rabbit

Powerful antioxidant acat inhibitors exhibit in vitro anti-inflammatory properties

Platelet inhibition by an L-arginine-derived substance released by IL-1 beta-treated vascular smooth muscle cells

The induction of nitric oxide synthase activity is inhibited by TGF-beta 1, PDGFAB and PDGFBB in vascular smooth muscle cells

366 F16357 regulates in vitro bladder contractility mediated by Protease Activated Receptors

Sulfonamide derivatives of benzylamine block cholesterol biosynthesis in HepG 2 cells: A new type of potent squalene epoxidase inhibitors

Transforming growth factor-beta 1 inhibits L-arginine-derived relaxing factor(s) from smooth muscle cells

Metabolic syndrome: which definition for what treatment(s)?

Antipsychotic induced-hepatic gene dysregulations correlate with clinical metabolic side effects: A hypothesis of direct action on liver

Retinoid-Induced Potentiation of Epidermal Growth Factor Mitogenic Effect on Corneal Endothelial Cells

Cardiovascular drugs inhibit MMP-9 activity from human THP-1 macrophages

Suchergebnisse filtern